
Nutrien Ltd. (TSE:NTR – Free Report) – Equities research analysts at Zacks Research lowered their Q2 2026 earnings estimates for shares of Nutrien in a report released on Wednesday, April 15th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $3.27 for the quarter, down from their prior estimate of $3.32. The consensus estimate for Nutrien’s current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Nutrien’s Q3 2026 earnings at $1.03 EPS, FY2026 earnings at $6.07 EPS, Q1 2027 earnings at $0.94 EPS, Q4 2027 earnings at $1.12 EPS and FY2027 earnings at $5.91 EPS.
A number of other brokerages have also commented on NTR. TD Securities lifted their price target on Nutrien from C$72.00 to C$80.00 and gave the company a “buy” rating in a research note on Wednesday, February 18th. Wells Fargo & Company raised Nutrien from a “hold” rating to a “strong-buy” rating in a research note on Friday, March 13th. UBS Group lowered Nutrien from a “hold” rating to a “strong sell” rating in a research note on Thursday, March 26th. BNP Paribas Exane lowered Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 23rd. Finally, Jefferies Financial Group raised Nutrien from a “hold” rating to a “strong-buy” rating in a research note on Thursday, March 12th. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of C$80.00.
Nutrien Stock Performance
Shares of NTR stock opened at C$96.75 on Friday. The business’s 50-day moving average price is C$102.33 and its 200-day moving average price is C$90.80. Nutrien has a 12 month low of C$72.02 and a 12 month high of C$116.95. The firm has a market capitalization of C$46.55 billion, a price-to-earnings ratio of 20.76, a PEG ratio of 1.15 and a beta of 0.99. The company has a current ratio of 1.34, a quick ratio of 0.65 and a debt-to-equity ratio of 51.16.
Nutrien (TSE:NTR – Get Free Report) last posted its quarterly earnings results on Wednesday, February 18th. The company reported C$1.14 earnings per share for the quarter. Nutrien had a net margin of 8.44% and a return on equity of 9.13%. The company had revenue of C$5.34 billion for the quarter.
Key Headlines Impacting Nutrien
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Zacks raised its Q3 2026 EPS view to $1.03 (from $0.99), signaling a slightly stronger outlook for that quarter. MarketBeat
- Positive Sentiment: Zacks also increased its Q2 2027 EPS forecast to $2.58 (from $2.52), a small positive datapoint amid otherwise lower estimates. MarketBeat
- Negative Sentiment: Multiple downward revisions: Zacks cut Q2 2026 (to $3.27 from $3.32), Q1 2027 (to $0.94 from $0.96), Q4 2027 (to $1.12 from $1.22), Q4 2026 (to $1.11 from $1.17) and Q3 2027 (to $1.28 from $1.34). At the annual level Zacks trimmed FY2026 to $6.07 (from $6.11), FY2027 to $5.91 (from $6.02) and FY2028 to $6.32 (from $6.51). These cuts indicate Zacks expects weaker profitability over the next several years, which is the main driver of negative sentiment. MarketBeat
About Nutrien
Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.
Further Reading
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
